Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples.

Baumhoer D, Tornillo L, Stadlmann S, Roncalli M, Diamantis EK, Terracciano LM.

Am J Clin Pathol. 2008 Jun;129(6):899-906. doi: 10.1309/HCQWPWD50XHD2DW6.

2.

Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.

Kandil DH, Cooper K.

Adv Anat Pathol. 2009 Mar;16(2):125-9. doi: 10.1097/PAP.0b013e3181992455. Review.

PMID:
19550373
3.

Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.

Filmus J, Capurro M.

FEBS J. 2013 May;280(10):2471-6. doi: 10.1111/febs.12126. Review.

4.

Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma.

Filmus J, Capurro M.

Mol Diagn. 2004;8(4):207-12. Review.

PMID:
15887976
5.

Discovery and diagnostic value of a novel oncofetal protein: glypican 3.

Wang SK, Zynger DL, Hes O, Yang XJ.

Adv Anat Pathol. 2014 Nov;21(6):450-60. doi: 10.1097/PAP.0000000000000043. Review.

PMID:
25299314
6.

[Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma].

Nishimura Y, Nakatsura T, Senju S.

Nihon Rinsho Meneki Gakkai Kaishi. 2008 Oct;31(5):383-91. Review. Japanese.

PMID:
18974622
7.

Update on precursor and early lesions of hepatocellular carcinomas.

Park YN.

Arch Pathol Lab Med. 2011 Jun;135(6):704-15. doi: 10.1043/2010-0524-RA.1. Review.

PMID:
21631263
8.

[Hepatocarcinogenesis in human liver].

Nagy P, László V, Schaff Z.

Magy Onkol. 2006;50(2):107-13. Review. Hungarian.

9.

Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.

Sakamoto M, Mori T, Masugi Y, Effendi K, Rie I, Du W.

Intervirology. 2008;51 Suppl 1:42-5. doi: 10.1159/000122603. Review.

PMID:
18544947
10.

Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma.

Jakubovic BD, Jothy S.

Exp Mol Pathol. 2007 Apr;82(2):184-9. Review. No abstract available.

PMID:
17258707
11.

Preneoplastic lesions in human hepatocarcinogenesis.

Libbrecht L, Desmet V, Roskams T.

Liver Int. 2005 Feb;25(1):16-27. Review.

PMID:
15698394
12.

Hepatic precancerous lesions and small hepatocellular carcinoma.

Hytiroglou P, Park YN, Krinsky G, Theise ND.

Gastroenterol Clin North Am. 2007 Dec;36(4):867-87, vii. Review.

PMID:
17996795
13.

Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma.

Allegretta M, Filmus J.

Anticancer Agents Med Chem. 2011 Jul;11(6):543-8. Review.

14.

[Recent developments in biopsy diagnosis of early and undefined liver tumors].

Longerich T, Schirmacher P.

Z Gastroenterol. 2009 Jan;47(1):30-6. doi: 10.1055/s-0028-1109088. Review. German.

PMID:
19156590
15.

Large liver cell dysplasia: a controversial entity.

Park YN, Roncalli M.

J Hepatol. 2006 Nov;45(5):734-43. Review.

PMID:
16982109
16.

Significance of hepatic preneoplasia in risk identification and early detection of neoplasia.

Bannasch P, Haertel T, Su Q.

Toxicol Pathol. 2003 Jan-Feb;31(1):134-9. Review.

17.

The evolving concept of tumor microenvironments.

Laconi E.

Bioessays. 2007 Aug;29(8):738-44. Review.

PMID:
17621638
18.

[Advances in the study of preneoplastic lesions of lung cancer].

Wang GF, Lai MD.

Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jan;27(1):55-7. Review. Chinese. No abstract available.

PMID:
14989828
19.

[New member of chip family--tissue microarray].

Deng ZH, Zhou JH.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Feb;29(1):102-4. Review. Chinese. No abstract available.

20.

Biology of pulmonary preneoplastic lesions.

Vermylen P, Roufosse C, Ninane V, Sculier JP.

Cancer Treat Rev. 1997 Jul;23(4):241-62. Review. No abstract available.

PMID:
9377595
Items per page

Supplemental Content

Support Center